| Name | Title | Contact Details |
|---|
Vitality Group changes the economics of healthcare by integrating expertise in wellness, insurance and technology to change the behaviors that lead to poorer health. Uniquely monetizing health in ways that actively encourage engagement in healthier lifestyles, Vitality provides benefits from day one to members, employers and society.
LUMEDX is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Oakland, CA. To find more information about LUMEDX, please visit www.lumedx.com
Avanti Hospitals currently owns and operates four acute care hospitals: East Los Angeles Doctors Hospital, Memorial Hospital of Gardena, Community Hospital of Huntington Park, and Coast Plaza Hospital, all located near Los Angeles, California. Our mission is to provide affordable, high quality healthcare services to our community with consistency and compassion. Avanti is committed to cooperating with and supporting the long-term needs and objectives of each community we serve. We understand the impact we have on our communities and the potential to improve overall health. We have worked hard to establish a reputation of quality and trust in our communities, including local physicians and governments. At each of our hospitals, we seek to implement community support through a variety of initiatives that are specific to each individual community. With nearly 2,000 employees and over 775 physicians, the Avanti team is committed to delivering the highest quality care to our patients through a broad range of medical services. We also continue to add new programs and technology to meet the meet the growing needs of the communities we serve.
Hometown Health is a Reno, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
WAVE Life Sciences is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering exceptional treatment options for patients. Given the unique versatility of its chemistry platform, WAVE`s pipeline will span multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded RNAi.